Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone acetonide plus 5-fluorouracil for preserving trabeculectomy bleb function after cataract surgery in glaucoma
ACTRN12611000336987Phase 4Recruiting
- Sponsor
- The Royal Victorian Eye and Ear Hospital
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of triamcinolone acetonide and fluorouracil in Glaucoma and Glaucoma filtration surgery failure (GFSF) (2 arms), sponsored by The Royal Victorian Eye and Ear Hospital. Primary endpoint: Proportion of participants with intraocular pressure >6 mmHg and <18 mmHg without glaucoma medications. Started Jun 2011; status: recruiting.
02
Drugs
triamcinolone acetonidefluorouracil
03
Conditions
GlaucomaGlaucoma filtration surgery failure (GFSF)
Beyond the preview
Go deeper on ACTRN12611000336987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000336987.